Award
Delivery Order #SPE2DR26FCEU2
Delivery Order Awarded to DMS Pharmaceutical Group for Critical Medication Supply
Buyer
Defense Logistics Agency
Award Amount
$6.35
Ceiling
$6.35
Awarded
February 12, 2026
Period of Performance
Feb 12, 2026 – Feb 13, 2026
Identifier
SPE2DR26FCEU2
NAICS
325411
This delivery order contract, under the broader indefinite-delivery vehicle (IDV) held by DMS Pharmaceutical Group Inc., focuses on the procurement of a specific pharmaceutical product, ROBRAFEN DM 200-20 MG/20 ML LIQ 118ML. DMS Pharmaceutical Group, a company specializing in pharmaceuticals and healthcare solutions, is tasked with supplying this essential medication to support federal healthcare programs. The contract serves to ensure the agency's continued access to critical medications, contributing significantly to the maintenance of public health. The scope of work involves the timely delivery of this specified pharmaceutical product to a designated location in Park Ridge, Illinois, within a very short timeframe spanning just two days. This award follows a multi-year IDV contract that establishes a longer-term partnership facilitating such delivery orders. The contract was awarded through the existing IDV vehicle, indicating a streamlined procurement process likely under competitive terms consistent with federal purchasing regulations.
Description
4570851312!ROBAFEN DM 200-20 MG/20 ML LIQ 118ML